Advertisement

International Urology and Nephrology

, Volume 51, Issue 2, pp 223–229 | Cite as

Low serum folic acid can be a potential independent risk factor for erectile dysfunction: a prospective case–control study

  • Attia Abd Allah Attia
  • Mohamed Abd El Mawgood Amer
  • Mamdouh Hassan
  • Sameh Fayek GamalEl DinEmail author
Urology - Original Paper

Abstract

Purpose

The purpose of the study was to compare serum level of folic acid (FA) in patients with erectile dysfunction (ED) versus healthy controls and to assess its correlation with other well-known confounders for ED.

Methods

Our prospective study compared FA in 60 patients with ED versus 30 healthy controls. Patients were excluded if they had any hormonal disorders, Peyronie’s disease, or decompensated systemic illnesses. ED was evaluated by the validated Arabic version of the abbreviated five-item form of the International Index Of Erectile Function and confirmed by penile duplex. Serum FA level was assayed using ELIZA. Mann–Whitney, Kruskal–Wallis, and Chi-square tests and Spearman correlation were used as appropriate and confirmed by logistic regression model.

Results

Our study revealed that the median FA of the cases and the controls were 7.1 ng/mL and 13.4 ng/mL, respectively, and this difference was of high statistical significance (p < 0.001). Moreover, our study demonstrated significant relations between serum FA with DM, HTN, smoking, age, and cholesterol (p 0.01, 0.03, 0.014, 0.001, and 0.015, respectively). Our study showed that the best cut-off point of serum FA to detect patients with ED was found to be ≤ 9.42 with sensitivity of 80.00%, specificity of 93.33% and area under curve (AUC) of 91.3%.

Conclusion

Serum FA level decreased as the severity of ED increased even after adjustment of age, serum testosterone, DM, HTN, and smoking. FA deficiency might be an independent risk factor of ED.

Keywords

Erectile dysfunction IIEF-5 Serum folic acid Severity of erectile dysfunction 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethical committee.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Hatzimouratidis K, Giuliano F, Moncada I, Muneer A, Salonia A, Verze P (2016) Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation 62(3):543–552Google Scholar
  2. 2.
    Porst H (2009) Premature ejaculation. Urol A 48:663–674CrossRefGoogle Scholar
  3. 3.
    Zhengyan T, Li D, Zhang X, Yi L, Zhu X, Zeng X, Tang Y (2014) Comparison of the simplified International Index of erectile function (IIEF-5) in patients of erectile dysfunction with different pathophysiologies. BMC Urol 14:52CrossRefGoogle Scholar
  4. 4.
    Antonio A, Bruzziches R, Francomano D, Natali M, Gareri P, Spera G (2010) Endothelial dysfunction and erectile dysfunction in the aging man. Int J Urol 17:38–47CrossRefGoogle Scholar
  5. 5.
    Zhongjian C, Yang X, Wang H (2010) Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev 5(2):158–165Google Scholar
  6. 6.
    Yang HF, Kao TW, Lin YY et al (2017) Does serum homocysteine explain the connection between sexual frequency and cardiovascular risk? J Sex Med 14:910–917CrossRefPubMedGoogle Scholar
  7. 7.
    Yan WJ, Yu N, Yin TL, Zou YJ, Yang J (2014) A new potential risk factor in patients with erectile dysfunction and premature ejaculation: folate deficiency. Asian J Androl 16:902–906CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Hamidi Madani A, Asadolahzade A, Mokhtari G, Shahrokhi Damavand R, Farzan A, Esmaeili S (2013) Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus. J Sex Med 10:1146–1150CrossRefPubMedGoogle Scholar
  9. 9.
    Cui S, Li W, Lv X, Wang P, Gao Y, Huang G (2017) Folic acid supplementation delays atherosclerotic lesion development by modulating MCP1 and VEGF DNA methylation levels in vivo and in vitro. Int J Mol Sci 18(5):990CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Shamloul R, Ghanem H, Abou-zeid A (2004) Validity of the Arabic version of the sexual health inventory for men among Egyptians. Int J Impot Res 16:452–455CrossRefPubMedGoogle Scholar
  11. 11.
    Cappelleri JC, Rosen RC (2005) The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 17:307–319CrossRefPubMedGoogle Scholar
  12. 12.
    Karabakan M, Erkmen AE, Guzel O, Aktas BK, Bozkurt A, Akdemir S (2016) Association between serum folic acid level and erectile dysfunction. Andrologia 48:532–535CrossRefPubMedGoogle Scholar
  13. 13.
    Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, Roger VL, Jacobsen SJ (2009) A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 84(2):108–113CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    Neelam C, Singh NK, Banerjee BD, Bala K, Basu M, Sharma D (2014) Intergenotypic variation of vitamin B12 and folate in AD: in north indian population. Ann Indian Acad Neurol 17(3):308–312CrossRefGoogle Scholar
  15. 15.
    Vardavas CI, Linardakis MK, Hatzis CM, Malliaraki M Saris WH, Kafatos AG (2008) Smoking status in relation to serum folate and dietary vitaminintake. Tob Induc Dis 4:8.  https://doi.org/10.1186/1617-9625-4-8 CrossRefPubMedCentralPubMedGoogle Scholar
  16. 16.
    Scazzone C, Bono A, Tornese F, Arsena R, Schillaci R, Buter D, Cottone S (2014) Correlation between low folate levels and hyperhomocysteinemia, but not with vitamin B12 in hypertensive patients. Ann Clin Lab Sci 44(3):286–290PubMedGoogle Scholar
  17. 17.
    Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274(13):1049–1057CrossRefPubMedGoogle Scholar
  18. 18.
    Clarke R, Lewington S, Landray M (2003) Homocysteine, renal function, and risk of cardiovascular disease. Kidney Int 63:S131–S133CrossRefGoogle Scholar
  19. 19.
    Cheng Z-J, Yang X, Wang H (2009) Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev 5(2):158–165CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Zhang Z, Xu Z, Dai Y, Chen Y (2017) Elevated serum homocysteine level as an independent risk factor for erectile dysfunction: a prospective pilot case-control study. Andrologia.  https://doi.org/10.1111/and.12684 CrossRefPubMedGoogle Scholar
  21. 21.
    Sansone M, Sansone A, Romano M, Seraceno S, Di Luigi L, Romanelli F (2017) Folate: a possible role in erectile dysfuntion. Aging Male 21(2):116–120.  https://doi.org/10.1080/13685538.2017.1404022 CrossRefPubMedGoogle Scholar
  22. 22.
    Pfanzagl B, Tribl F, Koller E, Möslinger T (2003) Homocysteine strongly enhances metal-catalyzed LDL oxidation in the presence of cystine and cysteine. Atherosclerosis 168:39–48CrossRefPubMedGoogle Scholar
  23. 23.
    Qin X, Xu M, Zhang Y, Li J, Xu X, Wang X, Xu X, Huo Y (2012) Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials. Atherosclerosis 222:307–313CrossRefPubMedGoogle Scholar
  24. 24.
    Ebesunun MO, Obajobi EO (2012) Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases. Pan Afr Med J 12:48PubMedCentralPubMedGoogle Scholar
  25. 25.
    Kilicdag EB, Bagis T, Tarim E et al (2005) Administration of B group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial. Hum Reprod 20(6):1521–1528CrossRefPubMedGoogle Scholar
  26. 26.
    Feng Y, Shan MQ, Bo L, Zhang XY, Hu J (2015) Association of homocysteine with type 1 diabetes mellitus: a metaanalysis. Int J Clin Exp Med 8(8):12529–12538PubMedCentralPubMedGoogle Scholar
  27. 27.
    Sansone A, Cignarelli A, Sansone M, Romanelli F, Corona G, Gianfrilli D, Isidori A, Giorgino F, Lenzi A (2018) Serum homocysteine levels in men with and without erectile dysfunction: a systematic review and meta-analysis. Int J Endocrinol.  https://doi.org/10.1155/2018/7424792 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Mirone V, Imbimbo C, Bortolotti A et al (2002) Cigarette smoking as risk factor for erectile dysfunction: results from an Italian epidemiological study. Eur Urol 41(3):294–297CrossRefPubMedGoogle Scholar
  29. 29.
    Lubin JH, Couper D, Lutsey PL, Yatsuya H (2017) Synergistic and non-synergistic associations for cigarette smoking and non-tobacco risk factors for cardiovascular disease incidence in the atherosclerosis risk in communities (ARIC) study. Nicotine Tob Res 19(7):826–835PubMedGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Attia Abd Allah Attia
    • 1
  • Mohamed Abd El Mawgood Amer
    • 1
  • Mamdouh Hassan
    • 1
  • Sameh Fayek GamalEl Din
    • 2
    Email author
  1. 1.Dermatology & Andrology Department, Faculty of MedicineAl-Azhar UniversityCairoEgypt
  2. 2.Andrology & STDs Department, Kasr Al-Ainy Faculty of MedicineCairo UniversityGizaEgypt

Personalised recommendations